Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| 1 |
iShares MSCI ACWI ETF
ACWI
|
+$865M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$842M |
| 3 |
Direxion Daily 20+ Year Treasury Bull 3X Shares
TMF
|
+$787M |
| 4 |
iShares MSCI India ETF
INDA
|
+$760M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$725M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.17B |
| 3 |
Microsoft
MSFT
|
+$2.16B |
| 4 |
Amazon
AMZN
|
+$1.17B |
| 5 |
Netflix
NFLX
|
+$865M |
Sector Composition
| 1 | Technology | 14.92% |
| 2 | Consumer Discretionary | 7.06% |
| 3 | Financials | 6.33% |
| 4 | Healthcare | 4.61% |
| 5 | Industrials | 4.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
iShares Preferred and Income Securities ETF
PFF
$14.7B
| $8.61M | ﹤0.01% |
267,214
+255,111
| +2,108% | +$8.22M |
|
902
MSCI
MSCI
$45.3B
| $8.61M | ﹤0.01% |
15,359
-9,971
| -39% | -$5.59M |
|
|
DFS
903
DELISTED
Discover Financial Services
DFS
| $8.6M | ﹤0.01% |
65,623
-1,837
| -3% | -$241K |
|
904
Roundhill Ball Metaverse ETF
METV
$328M
| $8.6M | ﹤0.01% |
691,718
-985,003
| -59% | -$12.2M |
|
905
WisdomTree International Hedged Quality Dividend Growth Fund
IHDG
$2.36B
| $8.59M | ﹤0.01% |
186,943
-175,483
| -48% | -$8.06M |
|
906
JPMorgan Hedged Equity Laddered Overlay ETF
HELO
$3.41B
| $8.56M | ﹤0.01% |
153,012
+54,552
| +55% | +$3.05M |
|
907
Hologic
HOLX
$14.8B
| $8.56M | ﹤0.01% |
109,793
-35,448
| -24% | -$2.76M |
|
908
Ares Management
ARES
$40.5B
| $8.56M | ﹤0.01% |
64,363
+15,727
| +32% | +$2.09M |
|
909
Academy Sports + Outdoors
ASO
$3.2B
| $8.55M | ﹤0.01% |
126,617
-37,849
| -23% | -$2.56M |
|
910
OR Royalties Inc.
OR
$6.75B
| $8.51M | ﹤0.01% |
518,612
+2,673
| +0.5% | +$43.9K |
|
911
Steris
STE
$24.9B
| $8.5M | ﹤0.01% |
37,828
+15,274
| +68% | +$3.43M |
|
912
Evolent Health
EVH
$1.08B
| $8.47M | ﹤0.01% |
258,320
-66,305
| -20% | -$2.17M |
|
913
LyondellBasell Industries
LYB
$17.8B
| $8.44M | ﹤0.01% |
82,551
-95,019
| -54% | -$9.72M |
|
914
Invesco Senior Loan ETF
BKLN
$6.88B
| $8.43M | ﹤0.01% |
398,436
-3,799,297
| -91% | -$80.4M |
|
915
iShares US Home Construction ETF
ITB
$3.33B
| $8.42M | ﹤0.01% |
72,752
+43,770
| +151% | +$5.07M |
|
916
Cannae Holdings
CNNE
$1.13B
| $8.41M | ﹤0.01% |
378,182
+306,716
| +429% | +$6.82M |
|
917
Plug Power
PLUG
$1.74B
| $8.4M | ﹤0.01% |
2,442,243
+473,016
| +24% | +$1.63M |
|
918
Schwab International Equity ETF
SCHF
$51.5B
| $8.4M | ﹤0.01% |
430,612
-642,986
| -60% | -$12.5M |
|
919
ProShares Short High Yield
SJB
$69.1M
| $8.38M | ﹤0.01% |
489,929
-411,269
| -46% | -$7.03M |
|
920
Leidos
LDOS
$23.8B
| $8.37M | ﹤0.01% |
63,812
+22,118
| +53% | +$2.9M |
|
921
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$278M
| $8.36M | ﹤0.01% |
253,742
-257,066
| -50% | -$8.47M |
|
922
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$576M
| $8.36M | ﹤0.01% |
264,596
+260,656
| +6,616% | +$8.24M |
|
923
Centene
CNC
$16.7B
| $8.35M | ﹤0.01% |
106,379
-22,966
| -18% | -$1.8M |
|
924
Portland General Electric
POR
$4.65B
| $8.3M | ﹤0.01% |
197,687
+144,900
| +274% | +$6.09M |
|
925
Dr. Reddy's Laboratories
RDY
$12.3B
| $8.3M | ﹤0.01% |
565,840
+541,215
| +2,198% | +$7.94M |
|